{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:06:09Z","timestamp":1794002769642,"version":"4.8.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.healun.2016.01.1223","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T04:32:03Z","timestamp":1455165123000},"page":"397-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":458,"title":["Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation"],"prefix":"10.1016","volume":"35","author":[{"given":"Deborah J.","family":"Levine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Aboyoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Belperio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Benden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald J.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desley","family":"Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Reinsmoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie D.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Verleden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Westall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Yusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2016.01.1223_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.healun.2010.05.006","article-title":"Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation","volume":"29","author":"Hachem","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib3","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.healun.2016.01.1223_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/TP.0b013e3181f6a07b","article-title":"Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes","volume":"90","author":"Singh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib7","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.healun.2014.07.018","article-title":"De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation","volume":"33","author":"Morrell","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.healun.2014.07.012","article-title":"De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation","volume":"33","author":"Safavi","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-6143.2004.00348.x","article-title":"Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection","volume":"4","author":"Baldwin","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2016.01.1223_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ki.2013.300","article-title":"Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies","volume":"85","author":"Halloran","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.healun.2016.01.1223_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.healun.2016.01.1223_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib16","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.4049\/jimmunol.152.10.5135","article-title":"Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity","volume":"152","author":"Russell","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/TP.0b013e31822872dd","article-title":"HLA antibody specification using single-antigen beads\u2014a technical solution for the prozone effect","volume":"92","author":"Schnaidt","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MOT.0b013e328355fb9b","article-title":"New approaches for detecting complement-fixing antibodies","volume":"17","author":"Tyan","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.01.1223_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/PAS.0b013e31825197ae","article-title":"The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies","volume":"36","author":"Yousem","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.healun.2016.01.1223_bib21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trre.2009.02.005","article-title":"Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection","volume":"23","author":"Murata","year":"2009","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.healun.2016.01.1223_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.humimm.2012.06.011","article-title":"Alloantibody induced platelet responses in transplants: potent mediators in small packages","volume":"73","author":"Kuo","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-009-8136-3","article-title":"Mechanisms involved in antibody- and complement-mediated allograft rejection","volume":"47","author":"Wasowska","year":"2010","journal-title":"Immunol Res"},{"key":"10.1016\/j.healun.2016.01.1223_bib24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.humimm.2012.07.330","article-title":"Role of complement and NK cells in antibody mediated rejection","volume":"73","author":"Akiyoshi","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib25","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humimm.2012.07.010","article-title":"Non-HLA-antibodies targeting angiotensin type 1 receptor and antibody mediated rejection","volume":"73","author":"Dragun","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib26","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.humimm.2011.09.004","article-title":"Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner","volume":"72","author":"Li","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib27","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.humimm.2012.07.332","article-title":"Endothelial molecules decipher the mechanisms and functional pathways in antibody-mediated rejection","volume":"73","author":"Sis","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib28","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.humimm.2012.06.012","article-title":"Mechanisms of human smooth muscle cell proliferation and transplant vasculopathy induced by HLA class I antibodies: in vitro and in vivo studies","volume":"73","author":"Trayssac","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib29","first-page":"446","article-title":"HLA class I antibody-mediated endothelial and smooth muscle cell activation. Curr Opin","volume":"17","author":"Zhang","year":"2012","journal-title":"Organ Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/tan.12381","article-title":"MHC class I signaling: new functional perspectives for an old molecule","volume":"83","author":"Tsai","year":"2014","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.healun.2016.01.1223_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOT.0000000000000040","article-title":"Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms","volume":"19","author":"Valenzuela","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib32","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.humimm.2012.06.014","article-title":"Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications","volume":"73","author":"Sarma","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.healun.2013.04.006","article-title":"Anti-major histocompatibility complex\u2013induced obliterative airway disease: selective role for CD4 and CD8 T cells in inducing immune responses to self-antigens","volume":"32","author":"Tiriveedhi","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib34","doi-asserted-by":"crossref","first-page":"e42370","DOI":"10.1371\/journal.pone.0042370","article-title":"Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease","volume":"7","author":"Takenaka","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2016.01.1223_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.182.1.309","article-title":"Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection","volume":"182","author":"Fukami","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib36","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.humimm.2012.07.012","article-title":"Signaling of endothelial cytoprotection in transplantation","volume":"73","author":"Charreau","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.healun.2012.11.005","article-title":"Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.healun.2014.06.006","article-title":"Reproducibility of complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies","volume":"33","author":"Roden","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib39","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/j.1600-6143.2004.00585.x","article-title":"Banff 2003 meeting report: new diagnostic insights and standards","volume":"4","author":"Racusen","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.healun.2013.10.022","article-title":"A new classification system for chronic lung allograft dysfunction","volume":"33","author":"Verleden","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib42","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1600-6143.2008.02467.x","article-title":"Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation","volume":"9","author":"Astor","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib44","first-page":"508","article-title":"Antibody-mediated rejection in lung transplantation: case reports","author":"Girnita","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2016.01.1223_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.trim.2012.08.002","article-title":"Antibody-mediated rejection in a lung transplant recipient after acute stroke","volume":"27","author":"Hayes","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jca.21270","article-title":"Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection","volume":"28","author":"Jackups","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.healun.2016.01.1223_bib47","unstructured":"Todd LA, Hayes D Jr. Diagnosis and management of antibody-mediated rejection following pediatric lung transplantation. In: Goldfarb S, Benden C, Sweet S, Kirklin JK, editors. Elsevier Inc., New York ISHLT Monograph on Pediatric Lung Transplantation; 2013:137-49."},{"key":"10.1016\/j.healun.2016.01.1223_bib48","first-page":"1","article-title":"Revision of the 1990 working formulation for the classification of pulmonary allograft rejection","volume":"15","author":"Yousem","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib49","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.healun.2014.01.867","article-title":"Comprehensive evaluation of lung allograft function in infants after lung and heart\u2013lung transplantation","volume":"33","author":"Hayes","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib51","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.healun.2005.05.015","article-title":"Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function","volume":"24","author":"Astor","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib52","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.healun.2013.08.017","article-title":"Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation","volume":"32","author":"Baum","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib53","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.athoracsur.2012.09.089","article-title":"Unilateral humoral rejection after reoperative single-lung transplant","volume":"95","author":"Beaty","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2016.01.1223_bib54","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s00595-012-0151-7","article-title":"Antibody-mediated rejection of a unilateral donor lung in bilateral living-donor lobar lung transplantation: report of a case","volume":"42","author":"Chen","year":"2012","journal-title":"Surg Today"},{"key":"10.1016\/j.healun.2016.01.1223_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2012.11.009","article-title":"Diagnosis and treatment of antibody mediated rejection in lung transplantation: a retrospective case series","volume":"28","author":"Daoud","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2016.01.1223_bib56","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.healun.2008.09.013","article-title":"Acute antibody-mediated rejection after lung transplantation","volume":"28","author":"Morrell","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/TP.0b013e3181c280f9","article-title":"Acute humoral rejection in a lung recipient: reversion with bortezomib","volume":"89","author":"Neumann","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosissup.2012.10.032","article-title":"Therapeutic apheresis in transplantation medicine, experience with cardiac and lung transplantation in Jena","volume":"14","author":"Rummler","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.healun.2016.01.1223_bib59","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1345\/aph.1Q509","article-title":"Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction","volume":"46","author":"Stuckey","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.healun.2016.01.1223_bib60","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.healun.2013.07.004","article-title":"Acute antibody-mediated rejection after lung transplantation","volume":"32","author":"Witt","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib61","first-page":"415","article-title":"Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection","volume":"17","author":"Badesch","year":"1998","journal-title":"J Heart Lung Transplant"},{"issue":"suppl","key":"10.1016\/j.healun.2016.01.1223_bib62","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1016\/j.healun.2004.06.022","article-title":"Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study","volume":"24","author":"Hadjiliadis","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-6143.2004.00650.x","article-title":"HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction","volume":"5","author":"Girnita","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib64","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.healun.2003.08.030","article-title":"HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection","volume":"23","author":"Girnita","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib65","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00007890-199803150-00008","article-title":"HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome","volume":"65","author":"Sundaresan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib66","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00007890-199904270-00012","article-title":"Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation","volume":"67","author":"Jaramillo","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib67","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","article-title":"Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation","volume":"12","author":"Hachem","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib68","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/TP.0b013e318176ae2c","article-title":"Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center\u05f3s experience","volume":"86","author":"Magee","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib69","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.01.1223_bib70","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2016.01.1223_bib71","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib72","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/TP.0b013e3182802f88","article-title":"Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximab","volume":"95","author":"Vo","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib73","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/TP.0b013e31827afb0f","article-title":"Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay","volume":"95","author":"Brugiere","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2016.01.1223_bib74","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201312-2160OC","article-title":"Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates","volume":"189","author":"Kim","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2016.01.1223_bib75","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0003-4975(00)01224-8","article-title":"Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients","volume":"69","author":"Lau","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2016.01.1223_bib76","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/ajt.12636","article-title":"Antibody desensitization therapy in highly sensitized lung transplant candidates","volume":"14","author":"Snyder","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2016.01.1223_bib77","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.athoracsur.2008.02.011","article-title":"Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients","volume":"85","author":"Shah","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2016.01.1223_bib78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/ajt.13076","article-title":"Survival in sensitized lung transplant recipients with perioperative desensitization","volume":"15","author":"Tinckam","year":"2015","journal-title":"Am J Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816012778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249816012778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:30:51Z","timestamp":1760949051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249816012778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1053249816012778"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2016.01.1223","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2016.01.1223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}